The Ractopamine LFD is a qualitative one-step competitive inhibition immunoassay for the detection of Ractopamine in animal urine. It detects the presence of Ractopamine at 2.5 ppb or higher concentrations by utilizing highly specific reactions between antibodies and the Ractopamine drug.
The Ractopamine lateral flow device (LFD) is designed solely for use in preliminary screening of undiluted swine urine samples. It is a competitive inhibition immunoassay for the qualitative detection of Ractopamine. The Ractopamine LFD provides only a preliminary qualitative analytical test result. Professional judgment should be applied to any test results, particularly when preliminary positive or negative results are used. LC-MS/MS is recommended as the method of choice for confirmation of positive results obtained with the Ractopamine LFD.
Features and Benefits
- Rapid results
- Accurate and easy-to-use
- Low levels of detection
Product Specifications
- 25 tests per kit
- 10 minute test time
- 2.5 ppb cut-off
Order Details
Product # | Product Description |
RT-LFD-25-SU-IDS | Ractopamine LFD kit for Urine |
Reference Materials
For additional information or questions about product SDS documents, please contact Neogen at SDS@neogen.com.